Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

There’s no question that most entrepreneurs thrive on action. But as the Roman philosopher Marcus Tullius Cicero so aptly put it: “Before beginning, plan carefully.” Careful planning is precisely the ...

As Gemini 3 rolls out, Google will look to solidify its AI turnaround and move to the forefront of the fiercely competitive ...

Google launches Gemini 3, its most powerful AI model yet, bringing advanced reasoning, new interactive Search experiences, ...

Google launches Gemini 3, its most intelligent AI Model ever till date. In this article, we will be learning about the ...

The rollou t includes Gemini 3 Pro, a new Deep Think mode, expanded multimodal learning workflows, redesigned app ...

Google has introduced Gemini 3, its latest artificial intelligence model, on 18 November 2025. Developed by Google DeepMind, ...

After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the ...

In this article, check out the latest information on Call of Duty Black Ops 7 Endgame mode, date, rewards, free mode and more details.

Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

Vertex ( ($VERX) ) has shared an update. On November 14, 2025, Vertex, Inc. entered into the First Amendment to its Amended and Restated Credit ...